ngs, type 2 patients to begin insulin therapy earlier without fear of needles. Oramed's oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes. (cute tech for gastric yuck) Intec Pharma is a drug development company, applying its innovative proprietary g

ings, type 2 patients to begin insulin therapy earlier without fear of needles. Oramed's oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes. (cute tech for gastric yuck) Intec Pharma is a drug development company, applying its innovative proprietary g

seases. In the aesthetic world the use of autolgous adipose stem cells has become widely accepted in Europe and Asia. Since the middle of 2009 when the US FDA published its laws on autologous stem cells the field has expanded rapidly. EFTA_R1_01484708 EFTA02419109 ReGen BioSciences has developed an in-